KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Shares Issued (2018 - 2025)

Moderna (MRNA) has disclosed Shares Issued for 8 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 45.45% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.0 million through Dec 2025, down 46.97% year-over-year, with the annual reading at $35.0 million for FY2025, 46.97% down from the prior year.
  • Shares Issued for Q4 2025 was $16.0 million at Moderna, up from $2.0 million in the prior quarter.
  • The five-year high for Shares Issued was $36.0 million in Q2 2021, with the low at $2.0 million in Q3 2025.
  • Average Shares Issued over 5 years is $16.8 million, with a median of $15.0 million recorded in 2023.
  • Peak annual rise in Shares Issued hit 108.11% in 2021, while the deepest fall reached 98.17% in 2021.
  • Over 5 years, Shares Issued stood at $28.0 million in 2021, then fell by 10.71% to $25.0 million in 2022, then plummeted by 40.0% to $15.0 million in 2023, then dropped by 26.67% to $11.0 million in 2024, then surged by 45.45% to $16.0 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $16.0 million, $2.0 million, and $14.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.